Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer

Cancer Letters

Volumn 316, Issue 2, 2012, Pages 196-203

  Liu, Hanshao ^a,b   Zhu, Lin ^c   Liu, Bingya ^d   Yang, Liu ^d   Meng, Xianxin ^a   Zhang, Wei ^a   Ma, Yueyun ^c   Xiao, Huasheng ^a,b  

^a NATIONAL ENGINEERING CENTER FOR BIOCHIP AT SHANGHAI   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Genome wide microRNA expression profile; Noninvasive biomarker; Serum microRNA

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 187; MICRORNA 371; MICRORNA 378; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; MALE; MICRORNAS; MIDDLE AGED; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84856018708     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.10.034     Document Type: Article

References (40)

1. Garcia M., Jemal A., Ward E.M., Center M.M., et al. Global cancer facts & figures 2007. Atlanta GA: Am. Cancer Soc. 2007, 1-50.
2. Parkin D.M., Bray F.I., Devesa S.S. Cancer burden in the year 2000, the global picture. Eur. J. Cancer 2001, 37:S4-S66.
3. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
4. di Mario F., Cavallaro L.G. Non-invasive tests in gastric diseases. Dig. Liver Dis. 2008, 40:523-530.
5. Wagner A.D., Grothe W., Haerting J., Kleber G., Grothey A., Fleig W.E. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J. Clin. Oncol. 2006, 24:2903-2909.
6. Nakane Y., Okamura S., Akehira K., Boku T., Okusa T., Tanaka K., Hioki K. Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer 1994, 73:2703-2708.
7. Marrelli D., Pinto E., De Stefano A., Farnetani M., Garosi L., Roviello F. Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Am. J. Surg. 2001, 181:16-19.
8. Kloosterman W.P., Plasterk R.H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 2006, 11:441-450.
9. Stefani G., Slack F.J. Small noncoding RNAs in animal development. Nat. Rev. Mol. Cell Biol. 2008, 9:219-230.
10. Lewis B.P., Burqe C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
11. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
12. Lee Y.S., Dutta A. MicroRNAs in cancer. Annu. Rev. Pathol. 2008, 4:199-227.
13. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B., Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105:10513-10518.
14. Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., Yerushalmi N., Benjamin H., Kushnir M., Cholakh H., Melamed N., Bentwich Z., Hod M., Goren Y., Chajut A. Serum MicroRNAs Are Promising Novel Biomarkers. PLoS ONE 2008, 3:e3148.
15. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Zhang Y., Wang J., Jiang X., Xiang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Wang J., Zen K., Zhang J., Zhang C.Y. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18:997-1006.
16. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., Banham A.H., Pezzella F., Boultwood J., Wainscoat J.S., Hatton C.S., Harris A.L. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 2008, 141:672-675.
17. Chin L.J., Slack F.J. A truth serum for cancer - microRNAs have major potential as cancer biomarkers. Cell Res. 2008, 18:983-984.
18. Resnick K.E., Alder H., Hagan J.P., Richardson D.L., Croce C.M., Cohn D.E. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol. 2009, 112:55-59.
19. Taylor D.D., Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 2008, 110:13-21.
20. Ng E.K., Chong W.W., Jin H., Lam E.K., Shin V.Y., Yu J., Poon T.C., Ng S.S., Sung J.J. Differential expression of microRNAs in plasma of colorectal cancer patients: a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381.
21. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc. 2008, 3:1101-1108.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 2001, 25:402-408.
23. Lee D.Y., Deng Z., Wang C.H., Yang B.B. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc. Natl. Acad. Sci. USA 2007, 104:20350-20355.
24. Feng M., Li Z., Aau M., Wong C.H., Yang X., Yu Q. Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation. Oncogene 2011, 30:2242-2251.
25. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., Mitchell P.S., Bennett C.F., Pogosova-Agadjanyan E.L., Stirewalt D.L., Tait J.F., Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. USA 2011, 108:5003-5008.
26. Iguchi H., Kosaka N., Ochiya T. Secretary microRNAs as a versatile communication tool. Commun. Integr. Biol. 2010, 3:478-481.
27. Pigati L., Yaddanapudi S.C., Iyengar R., Kim D.J., Hearn S.A., Danforth D., Hastings M.L., Duelli D.M. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS ONE 2010, 5:e13515.
28. Schneider J., Schulze G. Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer. Anticancer Res. 2003, 23:5089-5093.
29. Guo J., Miao Y., Xiao B., Huan R., Jiang Z., Meng D., Wang Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J. Gastroenterol. Hepatol. 2009, 24:652-657.
30. Yao Y., Suo A.L., Li Z.F., Liu L.Y., Tian T., Ni L., Zhang W.G., Nan K.J., Song T.S., Huang C. MicroRNA profiling of human gastric cancer. Mol. Med. Rep. 2009, 2:963-970.
31. Jiang Z., Guo J., Xiao B., Miao Y., Huang R., Li D., Zhang Y. Increased expression of miR-421 in human gastric carcinoma and its clinical association. J. Gastroenterol. 2010, 45:17-23.
32. Tanaka M., Oikawa K., Takanashi M., Kudo M., Ohyashiki J., Ohyashiki K., Kuloda M. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS ONE 2009, 4:e5532.
33. Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., Hu Z., Hood L.E., Galas D.J. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. USA 2009, 106:4402-4407.
34. Rhoades M.W., Reinhart B.J., Lim L.P., Burge C.B., Bartel B., Bartel D.P. Prediction of plant microRNA targets. Cell 2002, 110:513-520.
35. Tang G., Reinhart B.J., Bartel D.P., Zamore P.D. A biochemical framework for RNA silencing in plants. Gene Dev. 2003, 17:49-63.
36. Olsen P.H., Ambros V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev. Biol. 1999, 216:671-680.
37. Seggerson K., Tang L., Moss E.G. Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev. Biol. 2002, 243:215-225.
38. Te J.L., Dozmorov I.M., Guthridge J.M., Nguyen K.L., Cavett J.W., Kelly J.A., Bruner G.R., Harley J.B., Ojwang J.O. Identification of unique microRNA signature associated with lupus nephritis. PLoS ONE 2010, 5:e10344.
39. Wang W.L., Chatterjee N., Chittur S.V., Welsh J., Tenniswood M.P. Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol. Cancer 2011, 18:10:58.
40. Liu R., Zhang C., Hu Z., Li G., Wang C., Yang C., Huang D., Chen X., Zhang H., Zhuang R., Deng T., Liu H., Yin J., Wang S., Zen K., Ba Y., Zhang C.Y. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur. J. Cancer 2011, 47:784-791.